Medicinski Kisik Sapio Life (Oxygen)

When inhaled, oxygen diffuses across the alveolar membrane into the pulmonary capillaries, raising arterial oxygen tension. The higher tension creates a gradient that drives oxygen into tissues, where it participates in cellular respiration, ATP generation, and normal organ function.

The prescribed dose and flow rate are set by the treating clinician based on the patient’s oxygen saturation, underlying condition, and clinical response. Dosage is individualized and should follow the prescriber’s written order.

Limited specific data are available for oxygen therapy in pregnancy and lactation. Generally, supplemental oxygen is considered safe when clinically indicated, but the prescriber must weigh potential benefits against any theoretical risks and monitor both mother and fetus closely.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Medicinski Kisik Sapio Life is a compressed medical‑grade oxygen gas, comparable in purity to other pharmaceutical oxygen cylinders. Unlike liquid oxygen systems, it is stored at ambient pressure, offering ease of handling and rapid delivery, while meeting EU quality standards for therapeutic use.

Store the oxygen cylinders at ambient temperature, preferably below 25 °C, in an upright position. Keep them in a well‑ventilated area away from heat sources, open flames, or combustible materials. Protect the cylinders from physical damage and ensure the regulator is securely attached before use.

The product is administered by inhalation using a medical‑grade cylinder equipped with a flow regulator and appropriate delivery device (e.g., nasal cannula or face mask). The prescriber sets the flow rate, and the patient breathes the oxygen directly from the regulator‑controlled outlet.

The most serious risks include fire or explosion when oxygen contacts open flames or sparks, pulmonary oxygen toxicity from prolonged high‑concentration exposure, and hypercapnia in patients with chronic CO₂ retention, especially those with severe COPD.

Patients with untreated pneumothorax, severe chronic CO₂ retention without close monitoring, or those for whom high‑concentration oxygen is contraindicated should not receive this therapy unless a specialist determines it is safe. Additionally, individuals lacking proper ventilation in the treatment area should avoid use.